Comparison of the 3-month Strut Coverage After Coronary Stenting by Optical Coherence Tomography; Cilotax and DESyne

Status

Withdrawn

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02060175

Enrollment

Registered

2014-02-11

Start date

2014-02-28

Completion date

2014-08-31

Last updated

2015-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients in the Treatment of Subjects With All-comer Who Are to Undergo PCI

Keywords

Optical coherence tomography, Drug-eluting stent, Strut coverage

Brief summary

We will compare the stent coverage at 3 months by optical coherence tomography (OCT) between the Cilotax and DESyne drug-eluting stents (DES). The extent of the strut uncoverage has not been evaluated yet for both the Cilotax and DESyne and we first sought to decide the reference intervals using 40 samples (total 44 patients for each group considering 10% drop-out rate) as the pilot study.

Interventions

DEVICECilotax drug-eluting stents implantation

DEVICEDESyne drug-eluting stents implantation

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients ≥ 20 years old * Patients in the treatment of subjects with all-comer who are to undergo PCI

Exclusion criteria

* Pregnant women or women with potential childbearing * Life expectancy \< 1 year

Design outcomes

Primary

Measure	Time frame	Description
Stent coverage	up to 3 months after stent implantation	The percentage of stent uncoverage measured by OCT

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026